Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
58,390,925
-
Share change
-
+1,767,859
-
Total reported value
-
$369,592,679
-
Put/Call ratio
-
33%
-
Price per share
-
$6.33
-
Number of holders
-
107
-
Value change
-
+$11,847,838
-
Number of buys
-
51
-
Number of sells
-
36
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q4 2016
As of 31 Dec 2016 BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) had 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 58,390,925 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, VHCP Management II, LLC, RTW INVESTMENTS, LP, D. E. Shaw & Co., Inc., BlackRock Fund Advisors, VANGUARD GROUP INC, DEERFIELD MANAGEMENT CO, RA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and BlackRock Institutional Trust Company, N.A..
This table shows 107 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.